Remiges BioPharma Fund II, LP — Form D
Remiges BioPharma Fund II, LP of CAMBRIDGE, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-06-19. The offering totals $95.0M. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-06-19
- Form: D
- Accession: 0001779994-19-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $95.0M
- Remaining: $95.0M
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-342260
Issuer
- Name: Remiges BioPharma Fund II, LP
- CIK: 0001779994
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, 02142
- Phone: 617-401-2136
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Walter Olesiak | Director | New York, NY |
| Taro Inaba | Director | TOKYO, M0 |
| n/a Remiges BioPharma Fund GP II, Inc. | Director | Cambridge, MA |
| n/a Remiges BioPharma Fund GP II, Inc. | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More